CNBX Pharmaceuticals Inc. (CNBX) Debt Ratio (2015 - 2026)

CNBX Pharmaceuticals' (CNBX) quarterly Debt Ratio came in at 9.38 in Q2 2026, up 86.31% on a QoQ basis from 5.03 in Q1 2026.

CNBX Pharmaceuticals Inc. (CNBX) Debt Ratio (2015 - 2026) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 7 years of Debt Ratio data on file, last reported at 9.38 in Q2 2026.

Quarterly Debt Ratio changed N/A year-over-year to 9.38 in Q2 2026, while the trailing twelve-month figure through May 2026 was 9.38 (changed N/A YoY) and the FY2024 annual result came in at 41.27, up 1432.78% from the prior year.
Debt Ratio rose to 9.38 in Q2 2026, from 5.03 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 41.27 in Q3 2024 to a low of 0.58 in Q4 2023.
A 4-year average of 6.6 and a median of 2.69 in 2023 frame the typical range for Debt Ratio.
Annual changes were most pronounced in 2023 — Debt Ratio slumped 82.29% — and 2024, when it soared 1432.78%.
Tracing CNBX's Debt Ratio over 4 years: stood at 3.26 in 2022, then plunged by 82.29% to 0.58 in 2023, then jumped by 7048.48% to 41.27 in 2024, then slumped by 77.27% to 9.38 in 2026.
The last three Debt Ratio figures came in at 9.38 (Q2 2026), 5.03 (Q1 2026), and 41.27 (Q3 2024), per Business Quant data.

Download Data